Medical Journals

Fluctuation of the Dopamine Uptake Inhibition Potency of Cocaine, but Not Amphetamine, at Mammalian Cells Expressing the Dopamine Transporter.

Authors:
  • Ukairo Okechukwu T
  • Ramanujapuram Suneetha
  • Surratt Christopher K

From: Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Mellon Hall, Room 453, 600 Forbes Avenue, Pittsburgh, PA 15282, USA.

Brain research

  • Publish Date: Feb 2007
  • ISSN: 0006-8993
  • Volume: 1131
  • Issue: 1
  • Pages: 68-76
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ukairo Okechukwu T, Ramanujapuram Suneetha, Surratt Christopher K, et al. Fluctuation of the Dopamine Uptake Inhibition Potency of Cocaine, but Not Amphetamine, at Mammalian Cells Expressing the Dopamine Transporter.. Brain Res. Feb 2007;1131:68-76

Abstract

Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine uptake by interfering with dopamine transporter (DAT) function. The resultant potentiation of dopaminergic neurotransmission is associated with psychostimulant addiction. Fluctuations in dopamine uptake inhibition potency (DUIP) were observed for classical DAT blockers including cocaine, mazindol, methylphenidate (Ritalintrade mark) and benztropine in CHO cells expressing wild type DAT; cocaine potency also decreased in DAT-expressing non-neuronal COS-7 cells and neuronal N2A neuroblastoma cells. In contrast, the DAT substrate (+)-amphetamine did not display this DUIP fluctuation. In parallel experiments, no fluctuation was observed for the apparent binding affinities of these 5 drugs. The DUIP decrease appeared to correlate with an increase in cell surface DAT expression level, as measured by B(max) values and confocal microscopy. The fact that the DUIP profile of amphetamine diverged from that of the classical DAT blockers is consistent with the idea of fundamental differences between the mechanisms of abused psychostimulant DAT substrates and inhibitors. Identification of the cellular factors that underlie the DAT inhibitor DUIP fluctuation phenomenon may be relevant to anti-psychostimulant drug discovery efforts.

Mesh Headings (Keywords): Amphetamine, Amphetamine-Related Disorders, Animals, Benztropine, Binding, Competitive, Brain, Brain Chemistry, CHO Cells, COS Cells, Cell Line, Tumor, Cercopithecus aethiops, Cocaine, Cocaine-Related Disorders, Cricetinae, Cricetulus, Dopamine, Dopamine Plasma Membrane Transport Proteins, Dopamine Uptake Inhibitors, Mazindol, Methylphenidate, Neurons, Radioligand Assay


Check for Full Text / PubMed Unique Identifier (PMID): 17169338


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.